Liqui-Tablet: The Innovative Oral Dosage Form Using the Newly Developed Liqui-Mass Technology

Matthew Lam, Kofi Asare-Addo, Ali Nokhodchi

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)


In this study, an attempt was made to produce Liqui-Tablets for the first time. This was carried out through the compaction of naproxen Liqui-Pellets. The incentive to convert the novel Liqui-Pellet into Liqui-Tablet was due to the array of inherent advantages of the popular and preferred tablet dosage form. The study showed that naproxen Liqui-Tablet could be successfully produced and the rapid drug release rate (100% drug release ~ 20 min) could be achieved under pH 1.2, where naproxen is insoluble. It was observed that the different pH of the dissolution medium affected the trend of drug release from formulations with varying amounts of liquid vehicle. The order of the fastest drug-releasing formulations was different depending on the pH used. The presence of Neusilin US2 showed considerable enhancement in the drug release rate as well as improving Liqui-Tablet robustness and hardness. Furthermore, images from X-ray micro-tomography displayed a uniform distribution of components in the Liqui-Tablet. The accelerated stability studies showed acceptable stability in terms of dissolution profile.
Original languageEnglish
Article number85
Number of pages11
JournalAAPS PharmSciTech
Issue number3
Early online date1 Mar 2021
Publication statusPublished - 1 Apr 2021


Dive into the research topics of 'Liqui-Tablet: The Innovative Oral Dosage Form Using the Newly Developed Liqui-Mass Technology'. Together they form a unique fingerprint.

Cite this